CONMED Corporation Announces First Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
CONMED (CNMD) PT Raised to $73 at Needham & Company
April 26, 2018 6:54 AM EDTNeedham & Company raised its price target on CONMED (NASDAQ: CNMD) to $73.00 (from $71.00) while maintaining a Buy rating.
Analyst Mike Matson commented, "CNMD's 1Q18 revenue and EPS beat consensus and management raised its 2018 revenue and EPS guidance. Revenue growth slowed somewhat to 6.8% CC... More
Conmed (CNMD) Tops Q1 EPS by 9c; Raises Outlook
April 25, 2018 4:15 PM EDTConmed (NASDAQ: CNMD) reported Q1 EPS of $0.53, $0.09 better than the analyst estimate of $0.44. Revenue for the quarter came in at $202.1 million versus the consensus estimate of $196.4 million.
GUIDANCE:
Conmed raises FY2018 EPS to $2.15-$2.20, versus the consensus of $2.14.
For earnings history and earnings-related data on Conmed (CNMD) click here.
... More